Our study sought to describe ocular surface alterations at baseline and after 4 months of dupilumab treatment in patients with severe AD. Our findings highlight that all 25 patients showed ocular surface alterations prior to dupilumab treatment. Dupilumab may cause the worsening of clinical or subclinical pre-existing ocular alterations belonging to the spectrum of AKC.
Download full-text PDF |
Source |
|---|---|
| http://dx.doi.org/10.1111/bjd.20706 | DOI Listing |
Publication Analysis
Top Keywords
ocular surface
12
surface alterations
8
dupilumab treatment
8
insights ocular
4
surface disease
4
disease patients
4
patients atopic
4
atopic dermatitis
4
dermatitis treated
4
dupilumab
4
Similar Publications
Want AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!